Inventor · disambiguated record
David Philip Lane
Also filed as: LANE DAVID · LANE DAVID P · LANE DAVID PHILIP
19 granted patents·12 pending applications·349 citations·filing 1993–2024
94Inventor score
Files withAGENCY SCIENCE TECH & RES8CYCLACEL LTD7UNIV DUNDEE5ASLAN PHARMACEUTICALS PTE LTD1BALL KATHRYN LINDSAY1
Top patents by PatentIndex Score
31 records- 0190US7083983B2Inhibitors of the interaction between P53 and MDM2CANCER RES CAMPAIGN TECH·Filed 1997·Granted Aug 1, 2006·108 cites·15 claims
- 0288US6153391AInterruption of binding of MDM2 and P53 protein and therapeutic application thereofUNIV DUNDEE·Filed 1998·Granted Nov 28, 2000·80 cites·12 claims
- 0380US5770377AInterruption of binding of MDM2 and P53 protein and therapeutic application thereofUNIV DUNDEE·Filed 1995·Granted Jun 23, 1998·49 cites·11 claims
- 0479US9068165B2Therapeutic applications of P53 isoforms in regenerative medicine, aging and cancerUS HEALTH·Filed 2013·Granted Jun 30, 2015·2 cites·9 claims
- 0577US5702908AInterruption of binding of MDM2 and p53 protein and therapeutic application thereofUNIV DUNDEE·Filed 1994·Granted Dec 30, 1997·43 cites·5 claims
- 0674US11613568B2Anti-p53 antibodiesAGENCY SCIENCE TECH & RES·Filed 2017·Granted Mar 28, 2023·1 cites·12 claims
- 0773US2025263475A1Anti-P53 AntibodiesAGENCY SCIENCE TECH & RES·Filed 2024·Application pending·0 cites
- 0872US9994644B2mAB 2 anti-Met antibodyAGENCY SCIENCE TECH & RES·Filed 2014·Granted Jun 12, 2018·4 cites·11 claims
- 0969US12195526B2Anti-p53 antibodiesAGENCY SCIENCE TECH & RES·Filed 2023·Granted Jan 14, 2025·0 cites·11 claims
- 1065US8575121B2Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancerHARRIS CURTIS C·Filed 2008·Granted Nov 5, 2013·0 cites·8 claims
- 1165US2008249025A1Methods and Means For Inhibition of CDK4 ActivityCYCLACEL LTD·Filed 2008·Application pending·0 cites
- 1260US6569833B1Cyclin dependent kinase binding peptidesCYCLACEL LTD·Filed 1996·Granted May 27, 2003·18 cites·22 claims
- 1359US9944927B2Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancerTHE US SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES·Filed 2015·Granted Apr 17, 2018·0 cites·4 claims
- 1459US7141541B1Use of peptidesUNIV DUNDEE·Filed 2000·Granted Nov 28, 2006·1 cites·5 claims
- 1553US11225515B2Macrophage stimulating protein receptor (or RON—recepteur d'Origine Nantais) antibodies and uses thereofAGENCY SCIENCE TECH & RES·Filed 2017·Granted Jan 18, 2022·0 cites·11 claims
- 1653US2004214765A1Methods and means for inhibition of CDK4 activityBALL KATHRYN LINDSAY·Filed 2003·Application pending·0 cites
- 1752US6962792B1Methods and means for inhibition of Cdk4 activityCYCLACEL LTD·Filed 1997·Granted Nov 8, 2005·11 cites·26 claims
- 1851US6242201B1Identification of the P21WaF1-PCNA interaction site and therapeutic applications thereofCYCLACEL LTD·Filed 1995·Granted Jun 5, 2001·14 cites·16 claims
- 1949US2005137137A1Inhibitors of the Interaction between p53 and MDM2Filed 2004·Application pending·0 cites
- 2047US6613878B1PCNA binding substanceCYCLACEL LTD·Filed 1996·Granted Sep 2, 2003·7 cites·18 claims
- 2147US2022372125A1Antigen Specific Binding Domains and Antibody MoleculesASLAN PHARMACEUTICALS PTE LTD·Filed 2020·Application pending·0 cites
- 2246US2016046672A1STAPLING eIF4E INTERACTING PEPTIDESAGENCY SCIENCE TECH & RES·Filed 2014·Application pending·0 cites
- 2345US2004029791A1Cyclin dependent kinase binding compoundsCYCLACEL LTD·Filed 2002·Application pending·0 cites
- 2444US2013344140A1Novel pharmaceutical combinations and methods for treating cancerCHEOK CHIT FANG·Filed 2011·Application pending·0 cites
- 2544US2015276755A1Methods for determining resistance against molecules targeting proteinsAGENCY SCIENCE TECH & RES·Filed 2013·Application pending·0 cites
- 2643US2004146971A1Novel p53 inducible proteinFiled 2002·Application pending·0 cites
- 2743US2005153991A1Methods of treatment of chronic lymphocytic leukemia using roscovitineCYCLACEL LTD·Filed 2004·Application pending·0 cites
- 2835US2018172678A1Dynamic Light Scattering Nanoplatform For High-Throughput Drug ScreeningAGENCY SCIENCE TECH & RES·Filed 2016·Application pending·0 cites
- 2933US6140058AActivation of p53 proteinNEWBURN ELLIS·Filed 1993·Granted Oct 31, 2000·7 cites·17 claims
- 3030US9365508B2Aroyl thiourea derivativesLAIN SONIA·Filed 2010·Granted Jun 14, 2016·0 cites·14 claims
- 3130US6020149AMethods of screening for anti-microbial agents and for inhibiting microbial growthUNIV DUNDEE·Filed 1997·Granted Feb 1, 2000·4 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when David Philip Lane files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →